A comparison of some cardiovascular and skeletal muscle effects of 1-allyl-2-benzyl-piperidine and lidocaine.
D000498:Allyl Compounds / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001001:Anura; D001285:Atropine / Q000494:pharmacology; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004562:Electrocardiography; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D007545:Isoproterenol / Q000494:pharmacology; D008012:Lidocaine / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D009132:Muscles / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D010880:Piperidines / Q000008:administration & dosage / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D000498:Allyl Compounds; D000889:Anti-Arrhythmia Agents; D001593:Benzyl Compounds; D010880:Piperidines; D014665:Vasodilator Agents; C006466:1-allyl-2-benzyl-piperidine; D001285:Atropine; D008012:Lidocaine; D011433:Propranolol; D007545:Isoproterenol; D014403:Tubocurarine; D009638:Norepinephrine